Fiera Capital Corp Adaptive Biotechnologies Corp Transaction History

Fiera Capital Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$6.4 - $14.73 $230,067 - $529,514	-35,948 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$10.12 - $28.9 $13,742 - $39,246	-1,358 Reduced 3.64%	35,948 $499,000
Q4 2021 Feb 08, 2022	SELL	$25.17 - $36.85 $79,134 - $115,856	-3,144 Reduced 7.77%	37,306 $1.05 Million
Q3 2021 Nov 12, 2021	SELL	$30.02 - $39.87 $15,220 - $20,214	-507 Reduced 1.24%	40,450 $1.37 Million
Q2 2021 Aug 11, 2021	SELL	$32.22 - $44.59 $93,212 - $128,998	-2,893 Reduced 6.6%	40,957 $1.98 Million
Q1 2021 May 11, 2021	SELL	$37.26 - $67.74 $1.28 Million - $2.32 Million	-34,284 Reduced 43.88%	43,850 $1.77 Million
Q4 2020 Feb 09, 2021	BUY	$45.01 - $65.47 $160,640 - $233,662	3,569 Added 4.79%	78,134 $4.62 Million
Q3 2020 Nov 12, 2020	BUY	$35.79 - $48.81 $375,258 - $511,772	10,485 Added 16.36%	74,565 $3.63 Million
Q2 2020 Aug 07, 2020	BUY	$24.95 - $48.38 $1.6 Million - $3.1 Million	64,080 New	64,080 $3.1 Million

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Fiera Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Fiera Capital Corp with notifications on news.